DRUG

STUDY

ER MEDICATIONS

BY

LAURICE

R. LARIOSA, RN

Group A
RNHeals
VSMMC

Name of patient:Geyrosaga, Salvador Jr. Gonzales

5:10 am

Date/time of admission:

Age / sex/status: 61 years old / male

2009

Diagnosis

Ward

: ER- IM

DRUG ORDER

MECHANISM OF
ACTION

Generic
name
OMEPRAZOLE

Suppress gastric
secretion thus
relieving
gastrointestinal
Brand name
distress and
Losec
,
promoting ulcer
Prilosec
healingby inhibiting
hydrogen/potassium
ATPase enzyme
Classificatio
system in the
n
gastric parietal cell:
Gastrointestin
characterized as a
al,
proton
gastric acid pump
pump inhibitor
inhibitor, since it
blocks the final step
of acid production.
Route
IV

Dosage
4O mg

/ married

Source:
http://www.nursehu
ssein.com/drug-

:CVD

January 11, 2013 @

infarct

Right

MCA

s/p

Admitting physician: Dr. Fortuna, Audrey Rose Ram-as

INDICATION
treatment of
active
duodenal
ulcer,
gastroesoph
ageal reflux
disease
(GERD),
including
erosive
esophagitis
and
symptomatic
GERD;

CONTRAINDICATION
S

ADVERSE
EFFECT

NURSING RESPONSIBILITIES

Long-term use for

gastroesophageal
reflux disease,
duodenal ulcers;
lactation.

CNS:
Headache,
dizziness,

Establish rapport to patient

and SO
Follow the ten rights of the pt

GI:
Diarrhea,
abdominal
pain, nausea,
mild transient
increases in
liver function
tests

Monitor
Lab tests: urinalysis for
hematuria and proteinuria.
Periodic liver function tests
with prolonged use

Urogenital:
Hematuria,
proteinuria.
Skin:Rash.

Report any changes in

urinary elimination such as
pain or discomfort associated
with urination, or blood in
urine.
Tell so/ pt to Report SEVERE
DIARRHEA; drug may need to
be discontinued.

study-omeprazoleomepron-nexium/
Frequency
OD

Name of patient:Geyrosaga, Salvador Jr. Gonzales

5:10 am

Date/time of admission:

January 11, 2013 @

Age / sex/status: 61 years old / male / married

Diagnosis

Ward
as

Admitting physician: Dr. Fortuna, Audrey Rose Ram-

DRUG ORDER

: ER- IM

MECHANISM OF
ACTION

INDICATION

CONTRAINDICATION
S

: CVD infarct Right MCA s/p 2009

ADVERSE
EFFECT

NURSING RESPONSIBILITIES

Generic name
CITICHOLINE
Brand name
Zynapse,Soma
zasine,
CHOLINERV
Classification
NEUROTONICS,
NOOTROPICS
Route
IV

Citicoline seems to
increase a brain
chemical called
phosphatidylcholin
e. This brain
chemical is
important for brain
function. Citicoline
might also
decrease brain
tissue damage
when the brain is
injured thus
minimize the
attack of stroke

Head injury,
Cerebrovascul
ar disease,
Cerebral
surgery,
Parkinsons
disease,
alzheimers
disease

Any allergy or
hypersensitivity to
the drug
Conscious use for
patient with renal
and hepatic
damage

Age / sex/status: 61 years old / male / married

Observe the ten rights of

the patient
Educate so or patient on
importance of drug
compliance,
Remind the so or the
patient that supplement
should not be taken/given in
the late afternoon or at
night because it can cause
difficulty sleeping
Monitor patient for
neurologic status such as :
eye opening, speech and
motor function, pupillary
assessment, cranial nerve
assessment and vital signs

Dosage
1 AMPULE

Source:http://www.
webmd.com/vitami
nsFrequency
supplements/ingre
Q 12 HOURS
dientmono-1090CITICOLINE.aspx?
activeIngredientId
=1090&activeIngr
edientName=CITIC
OLINE#vit_uses
Name of patient:Geyrosaga, Salvador Jr. Gonzales
5:10 am

Body
temperature
elevation,
Headaches,
Nausea and
vomiting,
Diarrhea,

report any signs and

symptoms of adverse
reactions to the doctor.

Date/time of admission:
Diagnosis

January 11, 2013 @

: CVD infarct Right MCA s/p 2009

Ward
as
DRUG ORDER

: ER- IM

MECHANISM OF
ACTION

Generic name
Losartan

Lower blood press

ureby producing
peripheral
vasodilation, a
Brand name
similar
cozaar
pharmacologic
effects to ace
inhibitors. It
Classification
competitively
Angiotensin II inhibits angiotensi
Antagonist,
n II at receptor
Antihypertensiv site.
e
Source:
Route
Enteral feeding

Dosage
I tab 100 mg
Frequency
Morning/am

http://healthmad.c
om/conditions-anddiseases/losartancozaar-drugstudy/#ixzz2HkoV
pNO5

Admitting physician: Dr. Fortuna, Audrey Rose Ram-

INDICATION
Hypertension,
Treatment of
diabetic
neuropathy
with elevated
serum
creatinine and
proteinuria in
patient with
type 2
diabetis and a
history of
hypertension

CONTRAINDICATION
S

ADVERSE
EFFECT

Hyperkalemia,
Sensitivity to drug

Headache,
dizziness,
syncope,
insomnia,
Hypotension,
Rash

NURSING RESPONSIBILITIES

Establish rapport,
Provide bedside care ,
monitor patient vitals signs
before and after drug
administration especially
BP,
Know the ten rights of the
patients,
Check creatinine and liver
function,
If patient is taking diuretic
watch for signs of
hypotension,
Let patient / so know the
importance of drug
compliance,
The medication should not
be mix with alcohol,
Be ware of drug adverse
effect and report any
unusualties to doctor.

Name of patient:Geyrosaga, Salvador Jr. Gonzales

5:10 am

Date/time of admission:

January 11, 2013 @

Age / sex/status: 61 years old / male / married

Diagnosis

Ward
as

Admitting physician: Dr. Fortuna, Audrey Rose Ram-

DRUG
ORDER

: ER- IM

MECHANISM OF ACTION

INDICATION

CONTRAINDIC
ATIONS

: CVD infarct Right MCA s/p 2009

ADVERSE
EFFECT

NURSING
RESPONSIBILITIES

Generic
name
Mannitol

Brand name
Osmitrol

Classification
Osmotic
diuretic

Route
Intravenous
bolus

Elevates plasma osmolality,

causing water to flow from tissues,
such as brain and eyes, and from
CSF, into extracellular fluid,
thereby decreasing intracranial and
intraocular pressure.
As an osmotic diuretic, mannitol
increases the osmolarity of
glomerular filtrate, which
decreases water reabsorption. This
leads to increased excretion of
water, sodium, chloride, and toxic
substances.
As an irrigant, mannitol minimizes
the hemolytic effects of water used
as an irrigant and reduces the
movement of hemolyzed blood
from the urethra to the systemic
circulation, which prevents
hemoglobinemia and serious renal
complications.

Dosage
20 % @ 100
Source:http://medicaldrugstudy.info
cc
/mannitol-drug-study

To reduce
intracranial or
intraocular
pressure,
To prevent
oliguria or
acute renal
failure,
To promote
diuresis in
drug toxicity,
To provide
irrigation
during
transurethral
resection of
prostate gland

Frequency
Q 8hours

Name of patient:Geyrosaga, Salvador Jr. Gonzales

5:10 am
Age / sex/status: 61 years old / male / married

Contraindicat
ed in patients
hypersensitive
to drug.
Active
intracranial
bleeding
(except during
craniotomy),
anuria,
hepatic
failure,
hypersensitivi
ty to mannitol
or its severe
dehydration,
severe heart
failure, severe
pulmonary
congestion,
severe renal
insufficiency

Dehydration,
Anuria,
Headache,
Tachycardia,
Hypokalemia
(increases the
risk of digoxin
toxicity)
Chronic renal
failure

Observe 10 rights of
patients, establish
rapport,
Monitor Renal function
(BUN and Creatinine)
Check imbalance
in:Serum Electrolyte
(Sodium and Potassium),
Do not administer
mannitol with same line
with blood product,
Observe the IV site
regularly for infiltration,
Monitor weight and I&O
and v/s,
Monitor for dehydration
( poor skin turgor, dry
skin and thirst),

Give the mannitol in the

morning
Date/time of admission: January 11, 2013 @
Diagnosis

: CVD infarct Right MCA s/p 2009

Ward
as
DRUG ORDER
Generic name
PARACETAMOL

Brand name
AEKNIL

: ER- IM
MECHANISM OF
ACTION
Decreases fever by
inhibiting the effects of
pyrogens on the
hypothalamus heat
regulating centers& by a
hypothalamic action
leading to sweating &
vasodilatation.

Admitting physician: Dr. Fortuna, Audrey Rose Ram-

INDICATION
Treatment of fever

Classification
ANALGESIC,
antipyretics
Route
Intravenous

Source:

CONTRAINDIC
ATIONS

ADVERSE
EFFECT

NURSING
RESPONSIBILITIES

Contraindicat
ed to allergy
to
acetaminophe
n

Hypoglycaemia
,
Rush,
urticaria

Establish rapport with

so/ pt

intolerance to
tartrazine
(yellow dye
#5), alcohol,
table sugar,
saccharin

Assess pt fever by
Monitoring v/s esp.
before and after the
drug administration
temperature
Follow the ten rights of
the pt
Assess allergic reactions:
rash, urticaria; if these
occur, drug may have to
be discontinued

http://drugsfornursingstud
ents.blogspot.com/2009/10
/paracetamol.html

Dosage
1ampule
1000mg/1g

Frequency
PRN 38.0C
Name of patient:Geyrosaga, Salvador Jr. Gonzales
5:10 am

Date/time of admission:

January 11, 2013 @

Age / sex/status: 61 years old / male / married

Diagnosis

Ward
as

Admitting physician: Dr. Fortuna, Audrey Rose Ram-

: ER- IM

MECHANISM OF
ACTION

DRUG ORDER
Generic name
SIMVASTATIN

Brand name
Zocor
Classification
ANTIHYPERLIPIDEMI
C

Inhibits HMG
COA reductase
enzyme, which
reduces
cholesterol
synthesis; this
enzyme is
needed
for cholesterol
production

Route
Enteral feeding

Dosage
40 mg I tab

Frequency
OD @ hours
sleep(HS)

of

source:
http://www.docstoc.c
om/docs/56382195/D
rug-Study--Simvastatin

INDICATION

To reduce Low
density lipoprotein
(LDL) and for
treatment of
hyperlipidemiasby
increasing the
HDL(high density
lipoprotein)

: CVD infarct Right MCA s/p 2009

CONTRAINDIC
ATIONS

ADVERSE
EFFECT

Acute liver
disease or
unexplained
persistent
elevations of
serum
transaminases
(drug will
affect the liver
evaluation)

Back pain,
constipation,
diarrhea,
flushing
(dizziness,itchi
ng, redness,
tingling,
warmth),
headache,naus
e, runny or
stuffy nose,
stomach
upset

NURSING
RESPONSIBILITIES
Assess ptsnutrition:
nutritional status
Monitor triglycerides,
cholesterol
baseline and throughout
treatment
Assess liver function
tests prior to
therapy and periodically
thereafter
Instruct patient to take
drug with the evening
meal
( taking this enhances
absorption and increases
cholesterol biosynthesis)
Refer pt to dietrician
Tell patient to notify
physician if adverse
reactions occur,
particularly muscle

aches and
pains.
Monitor bowel pattern
daily

Name of patient:Geyrosaga, Salvador Jr. Gonzales

5:10 am

Date/time of admission:

January 11, 2013 @

Age / sex/status: 61 years old / male / married

Diagnosis

Ward
as

Admitting physician: Dr. Fortuna, Audrey Rose Ram-

: ER- IM

: CVD infarct Right MCA s/p 2009

DRUG ORDER
Generic name
AMLODIPINE
Brand name
Norvasc

Classification
Calcum
channel
blocker,
antihypertensiv
e,
Anti angina

Route
Enteral feeding

Dosage
5mg I tab

Frequency
OD (once
day)
@ afternoon

MECHANISM OF
ACTION
Amlodipine relaxes
peripheral and coronary
vascular smooth muscle.
It produces coronary
vasodilation by
inhibiting the entry of Ca
ions into the voltagesensitive channels of the
vascular smooth muscle
and myocardium during
depolarisation that
cause a reduction in
peripheral vascular
resistance and reduction
in blood pressure.
It also increases
myocardial O2 delivery
in patients with
vasospastic angina.

Source:http://www.mims.co
m/USA/drug/info/amlodipin
e/?
q=amlodipine&type=full

INDICATION
Treatment of
essential
hypertension and
angina

CONTRAINDIC
ATIONS

ADVERSE
EFFECT

NURSING
RESPONSIBILITIES

Allergy to
amlodipine
Hepatic or
renal
impairment

headache and
edema
(swelling) of
the lower
extremities.

Assess patient for

history
of allergy to amlodipine,
impaired hepatic or renal
function, sick sinus
syndrome, heart block,
or CHF

Sick sinus
syndrome
Heart block
Sick sinus
syndrome
Lactation

Monitor BP before and

after drug administration
Observe the ten rights of
the patient
Assess for adverse drug
reactions; report
irregular heartbeat,
swelling of the hands
and
feet
Instruct patient to take
drug with meals if
abdominal discomfort
occurs; advise pt on
eating small, frequent
meals for
nausea and vomiting